fbpx

molecules of the month

“compound 15a”

reversible ATX inhibitor w/ alt. binding mode

in vivo PD observed on oral dosing

from HTS screen and opt.

Bioorg. Med. Chem. Lett., Nov. 4, 2020

Novartis, Horsham, UK / Basel, CH

Structure of compound 15a
1 min read

“compound 15a” (Novartis reversible in vivo ATX inhibitor)


request a trial

Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.

Request a trial to access insights powering the pros in our industry.


already a member? log in: